Portrait der Gilead Sciences Aktie
Das Unternehmen Gilead Sciences aus USA ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Biotechnologie, Pharma tätig.
Gilead Sciences ist in mehr als 83 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares Nasdaq US Biotechnology UCITS ETF gewichtet Gilead Sciences mit 7,06% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Gilead Sciences Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Gilead Sciences am höchsten gewichtet ist Insgesamt in 83 ETFs enthalten
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
281 News & Informationen zur Gilead Sciences Aktie
Jounce Therapeutics Provides Update On INNATE Study And Discovery Pipeline Expansion, And Provides A Portfolio Update At 2021 R&D Day
– INNATE study rapidly advancing; updates to be provided on enrollment status and receptor occupancy; expansion cohorts expected to open for enrollment in
Gritstone Announces Management Changes, Including
EMERYVILLE, Calif., June 23, 2021 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing next…
EUROPEAN MIDDAY BRIEFING : Stocks Slip as PMI -2-
GFG Alliance Wednesday said it has penned a standstill agreement with Credit Suisse on the Australian unit that includes its Whyalla steelworks to complete a refinancing of that business following…
Illicit Covid-19 Drugs Bound for Mexico Seized by U.S. Authorities
Counterfeit or generic versions of remdesivir, an antiviral manufactured by Gilead Sciences, are arriving in the U.S. by plane from Bangladesh and India and being smuggled by individuals to Mexico.
Mastercard Foundation : Robin Washington nomm?u Conseil d'Administration par la Fondation Mastercard
Mastercard Foundation / Mot-clé : Identité Mastercard Foundation: Robin Washington nommé au Conseil d'Administration par la Fondation Mastercard 23-Juin-2021 / 10:50 CET/CEST…
Gilead Sciences Inc (GILD): Price Now Near $67.22; Daily Chart Shows An Uptrend on 100 Day Basis
Why Enochian BioSciences Was a Winner on Monday
The company scores an exclusive license for new potential coronavirus treatment technology.
Gilead's Remdesivir Reduces Mortality Rate In Hospitalized Patients With COVID-19
(RTTNews) – Gilead Sciences Inc. (GILD) announced positive data from three retrospective studies of the real-world treatment of patients hospitali…
NIO, Amazon, Newmont Goldcorp, Gilead Sciences, Twitter, Thermo Fisher, Caterpillar und McDonald’s: Diese Zahlen…
Zu den ganz besonders interessanten Quartalsberichten gehören am Donnerstag die Zahlenbekanntgaben bei Amazon und NIO….
3 Top Biotech Stocks You Shouldn't Ignore By StockNews
3 Top Biotech Stocks You Shouldn't Ignore
Merck, Partner Halt Covid-19 Treatment Trial for Hospitalized Patients
The company and a partner will move forward with a separate study testing their oral antiviral drug in treating outpatients who are at high risk of complications.
Cardinal Capital Management, Inc. Buys Becton, Dickinson and Co, Suncor Energy Inc, Merck Inc, Sells Canadian Tire Corp, CT Real Estate Investment Trust, Deere
Cardinal Capital Management, Inc. Buys Becton, Dickinson and Co, Suncor Energy Inc, Merck Inc, Sells Canadian Tire Corp, CT Real Estate Investment Trust, Deere, Stocks: BDX,SU,MRK,NTR,SAP,GILD,AFG,TRMLF,TFC,FISV,FNV,MSF, release date:Apr 14, 2021
Drugmakers Are Vying for a Multibillion-Dollar Market
Too bad there are issues with side effects.
U.S. FDA Grants Accelerated Approval To Trodelvy® For The Treatment Of Metastatic Urothelial Cancer
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Trodelvy ®
A Short Delay Is Still Bad News for AbbVie
Rinvoq's FDA approval decision could be a sign the drug class is under investigation.
5 Blue-Chip Biotech Stocks to Buy in 2021
Discover the best biotech stocks to buy for both long-term investors and short-term traders as the industry continues to grow.
Centre halts exports of antiviral drug Remdesivir amid rising Covid cases
Read more about Centre halts exports of antiviral drug Remdesivir amid rising Covid cases on Business Standard. Export is banned till the situation in the country improves
Startup behind AstraZeneca Covid-19 vaccine files for U.S. IPO
U.K.-based Vaccitech, spun out of the University of Oxford in 2016, has been aiming for valuation of around $700 million
Here Are the Most Exciting Vaccines in Moderna's Pipeline
There's more to the biotech than its coronavirus vaccine.
Gilead Sciences steigert die Dividende das sechste Jahr in Folge
Der Biotechnologiekonzern Gilead Sciences Inc. (ISIN: US3755581036, NASDAQ: GILD) erhöht die Quartalsdividende um 4,4 Prozent von 0,68 US-Dollar je Aktie auf 0,71 US-Dollar. Ausgezahlt wird die Dividende für das erste Quartal 2021 am 30. März 2021 (Record date: 15. März 2021). Auf das Jahr hochgerechnet zahlt Gilead 2,84 US-Dollar an seine Aktionäre aus. Beim derzeitigen Börsenkurs von 65,83 US-Dollar (Stand:
Peloton, Gilead Sciences und Activision Blizzard: Diese Zahlen könnten Sie erwarten
Am Donnerstagabend werden Anleger erfahren, wie sich der mutmaßliche Corona-Profiteur Peloton im Schlussquartal 2020 geschlagen hat. …
Gilead Sciences (GILD) Gains As Market Dips: What You Should Know
Gilead Sciences (GILD) closed at $63.33 in the latest trading session, marking a +1.49% move from the prior day.
Gilead Sciences (GILD) Presents At 39th Annual JPMorgan Virtual Healthcare Conference – Slideshow (NASDAQ:GILD)
A reinvigorated Alzheimer's treatment and gene-therapy setbacks: 3 winners and 3 losers from the healthcare industry's most important event of the year
Gene therapy biotechs were overshadowed and struggled, while a highly debated theory on treating Alzheimer's disease got a boost.
Corporate Backers Reevaluate Donations To Carter, Other Objectors
Top Georgia companies as well as U.S. pharmaceutical and medical firms that count among Rep. Buddy Carter’s leading campaign donors are re-evaluating their association with politicians like the Pooler Republican in the wake of last week’s upheaval on Capitol Hill.
5 things to know before the stock market opens Friday
Dow futures fell Friday, with Dow-stock JPMorgan providing limited support after reporting better-than-expected quarterly earnings and revenue.
Strides Pharma arm gets USFDA nod for HIV treatment drug
The approved medicine slows down HIV spread and prescribed along with other medications to treat adults and children.
Strides Pharma Science arm gets USFDA nod for HIV treatment medicine
Read more about Strides Pharma Science arm gets USFDA nod for HIV treatment medicine on Business Standard. Strides Pharma Science said its step-down wholly-owned subsidiary, has received approval from the USFDA for Emtricitabine and Tenofovir Disoproxil Fumarate tablets, used to treat HIV
U.S. potentially facing ‘perpetual infection’ of Covid in spring as new variants spread, warns Dr. Scott Gottlieb
Dr. Scott Gottlieb warned of a potentially dire spring and summer without protective immunity as new, highly transmissible Covid variants appear globally.
Biden unveils sweeping plan to combat the Covid pandemic in the U.S.
President-elect Biden unveiled a sweeping plan to combat the pandemic in the U.S., which includes investing billions in a nationwide Covid-19 vaccine campaign.
Gilead Committed to Distributing Covid Treatment Remdesivir
Meine Aktien-Watchlist für Januar 2021 – Jung in Rente
Mein stetig wachsendes Depot bringt mich der finanziellen Freiheit jeden Tag ein Stück näher. Dies ist meine Watchlist für Januar 2021.
T-Mobile and Sprint — and 5 Other Surprising Company Mergers During COVID-19
While the economy largely came screeching to a halt this spring, that hasn't meant that the work of people in the mergers and acquisitions department came to a halt. If anything, major disruptions can…
Don’t Miss Out on Rampant Biotech Mergers with the SBIO ETF
Large cap biotechnology companies are flush with cash, and they're on the prowl for takeover targets.
3 Top Biotech Picks for January
Buy these three biotech stocks before they take off.
Is Gilead Sciences a Good Coronavirus Stock to Buy?
The biotech made headlines last year as the first to market a coronavirus treatment. What's in store for it in 2021?
Beigene Surges Closer To Breakout On $2.2 Billion Deal With Novartis
Beigene stock rose Tuesday on a cancer deal with Novartis worth up to $2.2 billion, as Vir Biotechnology announced a hepatitis B deal with Gilead Sciences.
Why Vir Biotechnology Stock Vaulted Higher Today
The biotech announced updates about collaborations with two big partners.
Covid strain found in South Africa ‘could evade’ Eli Lilly's antibody drug, CEO warns
“The South African variant … is the one of concern. It has more dramatic mutations to that spike protein,” Eli Lilly CEO Dave Ricks said.
Gilead CEO: We Expect Remdesivir To Work On New COVID-19 Strains
Daniel O’Day, the CEO of Gilead Sciences Inc. (NASDAQ: GILD), told CNBC on Monday that the drugmaker expects the antiviral drug to be fully effective …